| __timestamp | Merck & Co., Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 16768000000 | 9216000000 |
| Thursday, January 1, 2015 | 14934000000 | 8296000000 |
| Friday, January 1, 2016 | 13891000000 | 10044000000 |
| Sunday, January 1, 2017 | 12775000000 | 11560000000 |
| Monday, January 1, 2018 | 13509000000 | 10558000000 |
| Tuesday, January 1, 2019 | 14112000000 | 9351000000 |
| Wednesday, January 1, 2020 | 13618000000 | 8933000000 |
| Friday, January 1, 2021 | 13626000000 | 8284000000 |
| Saturday, January 1, 2022 | 17411000000 | 7952000000 |
| Sunday, January 1, 2023 | 16126000000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Unlocking the unknown
In the competitive pharmaceutical industry, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Merck & Co., Inc. and Teva Pharmaceutical Industries Limited from 2014 to 2023. Over this period, Merck consistently maintained a higher cost of revenue, peaking in 2022 with a 27% increase from its lowest point in 2017. In contrast, Teva's cost of revenue showed a downward trend, decreasing by approximately 13% from 2016 to 2023. This divergence highlights Merck's expansive operations and Teva's strategic cost management. The data suggests that while Merck invests heavily in its production capabilities, Teva focuses on optimizing its cost structure. Understanding these dynamics provides valuable insights into each company's operational strategies and market positioning.
Cost of Revenue Comparison: Eli Lilly and Company vs Merck & Co., Inc.
Cost of Revenue Comparison: AbbVie Inc. vs Merck & Co., Inc.
Merck & Co., Inc. vs Regeneron Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Merck & Co., Inc. vs Insmed Incorporated
Cost of Revenue Trends: Merck & Co., Inc. vs Evotec SE
Cost Insights: Breaking Down Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Limited's Expenses
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Neurocrine Biosciences, Inc.
Teva Pharmaceutical Industries Limited vs Walgreens Boots Alliance, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Grifols, S.A.'s Expenses
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Vericel Corporation
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Iovance Biotherapeutics, Inc.